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Melanin-concentrating hormone (MCH), the neuropeptide produced mainly in the hypothalamus, plays 
an operative role in regulating food intake and the sleep/wake cycle. Considering that these physiological 
functions pursue diurnal variations, we checked whether the total hypothalamic MCH level depends on 
the time of the day. The aggregated MCH peptide content of the whole MCH neuron population was 
significantly higher at the end of the sleeping period (lights on), than at the end of the active period (lights 
off). This result, together with earlier observations, indicates that in contrast to the MCH gene expression, 
the level of MCH peptide is object of circadian variation in the hypothalamus. 
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INTRODUCTION
The hypothalamus holds the light-driven, genetically defined biological clock of 
mammals, as well as key structures necessary for the integration of environmental 
factors, such as food availability, social and meteorological conditions [8, 19].
It is particularly important to handle energy homeostasis during different levels of 
food availability. A complex hypothalamic neural network, including melanin-con-
centrating hormone (MCH) and orexin producing neurons, two discrete but spatially 
overlapping neuron populations contribute to the regulation of energy homeostasis on 
a large scale. Interestingly, the very same neurons are partakers of the circuit which 
influence the sleep–wake cycle.
In the mammalian brain MCH producing neurons occur within a rostro-caudally 
restricted region of the hypothalamus, first of all in the lateral hypothalamic area 
(LHA) and in the zona incerta (ZI) [3, 17]. Mapping of the distribution of MCH neu-
ron perikarya and their projections in the rat [1, 2, 5] and mouse brain [3, 4] revealed 
the presence of MCH neuron somata in the lateral hypothalamic area, including the 
perifornical region, the rostromedial zona incerta, the posterior hypothalamic nucle-
us, and the capsule of the ventromedial nucleus, as often as not breaching the cyto-
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architectonic borders. Notwithstanding this restricted localization of the perikarya, 
MCH conveying projections reach a wide variety of target areas within the CNS and 
on the periphery. Regions affected include, among others, those involved in regulat-
ing feeding behaviour (e.g. lateral septum, nucleus accumbens) and those promoting 
arousal state (e.g. tuberomammillary nucleus, basal forebrain, locus coeruleus, vent-
rolateral periaqueductal gray, dorsal raphe), making this neuropeptide a potential 
candidate to constitute functional link between physiological processes [16, 22]. 
Two MCH neuron subpopulations are present in the hypothalamus: neurons con-
taining MCH as the only neuropeptide – classified as type A MCH neurons – and 
those expressing another neuropeptide, the cocaine- and amphetamine regulated 
transcript (CART) and the neurokinin 3 receptor as well, denoted as type B MCH 
neurons. The two subpopulations are partially segregated within the hypothalamus: 
laterally and caudally the majority of the MCH neurons belong to type A, while type 
B MCH neurons are predominating medially and in the rostral ZI. Due the imperfect-
ness of their spatial segregation, immunohistochemical identification is needed to tell 
the perikarya of the two subpopulations apart. The projections of type A and type B 
MCH neurons are principally directed towards the brainstem and the telencephalon, 
respectively [4, 5]. The functional importance of the coexpression of MCH and 
CART is unknown for the time being.
MCH has for long been known as a potent orexigenic neuropeptide, influencing 
both feeding behaviour and energy expenditure [13, 14, 16]. Fasting is known to 
increase the expression of MCH mRNA [18]. MCH is also a central player in the 
promotion and stabilization of sleep [7, 10–12, 21]. It has been suggested that MCH 
is affecting the pathophysiology of depression as well [21]. 
Considering the circadian rhythm of these physiological processes, it is plausible 
to suppose diurnal variations in the functioning of the MCHergic system. Nevertheless, 
available data are scanty.
Harthoorn et al. [9] analysed individual MCH neurons in the rat hypothalamus. 
They detected constant levels of MCH mRNA and peptide content at ZT2 and ZT14. 
(ZT stands for Zeitgeber time – “time giver” in German language. ZT0 traditionally 
corresponds to turning the lights on.) Similarly, statistically significant correlations 
were not found between the periodic expression of MCH and orexin genes with food 
intake in mouse hypothalamus [20].
In a recent comprehensive study, Dias Abdo Agamme et al. [6] measured the level 
of the MCH peptide by ELISA in the cerebrospinal fluid, along with the expression 
of the MCH gene (Pmch) in the hypothalamus, and the expression of the MCH recep-
tor gene in the frontal cortex and the hippocampus, during active and sleep phases. 
Under undisturbed conditions all parameters were independent from the phases, 
excepting the MCH receptor expression, which was significantly higher when sleep 
predominated. Disturbances of the sleep–wake cycle, on the other hand, induced day/
night differences in CSF levels of MCH and in Pmch gene expression.
In the present study, we have undertaken to test directly the MCH levels in the 
mouse hypothalamus at the end of the active and sleep phases by immunohistochem-
ical assessment of the total MCH peptide content.
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MATERIALS AND METHODS
Animals and tissue preparation
Young adult (30–34 g) Crl:NMRI BR male mice (Toxi-Coop Zrt, Hungary) were used 
during the experiments. 
Mice were kept under standard conditions, with water and rodent chow ad libitum. 
A 12/12 h dark/light cycle was applied (lights on at 8:00 AM and off at 8:00 PM). 
Animals were divided into two groups: ZT0 and ZT12 group member mice were 
exterminated immediately after the end of the dark period, and immediately after the 
end of the light period, respectively.
Transcardial perfusion was done under anaesthesia with glutaraldehyde supple-
mented Zamboni’s fixative (4% paraformaldehyde, 0.4% glutaraldehyde, 15% satu-
rated picric acid in 0.1 M phosphate buffer, pH 7.4). After removal from the skull, 
brains were further incubated overnight at +5 °C in the same fixative without glutar-
aldehyde. A 50 μm coronal sections were cut with a vibratome.
The study was conducted in accordance with the 2010/63/EU Directive, with writ-
ten permission of the institutional Animal Health and Welfare Committee.
MATERIALS
Primary antibody
Anti-MCH: polyclonal, raised in rabbit (Sigma-Aldrich, M8440). Immunogen: key-
hole limpet hemocyanin (KLH)-coupled synthetic peptide corresponding to human 
MCH.
Techniques
Detection of MCH immunoreactivity
Sections containing the hypothalamus were processed for immunohistochemistry 
free-floating. All incubations and washings were carried out at room temperature 
(20–23 °C). 
Blocking of the non-specific binding sites with 20% normal donkey serum (Life 
Technologies) was followed by overnight incubation with anti-MCH (Sigma-Aldrich, 
dilution: ×10,000). Biotinylated anti-rabbit IgG secondary antibody (Amersham, 
dilution: ×100) and avidin-biotin-horseradish peroxidase (VECTASTAIN Elite ABC 
HRP Kit, Vector laboratories, Cat. No: PK-6100) were applied according to the 
manufacturer’s instructions. The 3,3’diaminobenzidine (DAB) was used as chromo-
gen. To assure the comparability of the results, the immunodetection procedure for all 
mice (ZT0 and ZT12 collectively) has been performed in parallel, as a single series. 
Complete rostro-caudal series of MCH neuron containing sections were considered 
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for further densitometric and statistical evaluation. Incomplete series (with failing or 
damaged sections) have been disregarded. At the end, three series of sections from 
each ZT group have been evaluated.
Densitometric evaluation
Immunolabelled sections were monitored and photographed by a Leica DM750 
microscope equipped with a Leica DMC2900 camera. On each section left and right 
sides of the hypothalamus were separately photographed with standardized illumina-
tion by using ×10 magnification. Photos (2048 × 1536 pixels) were converted into 8 
bit grayscale for the purpose of the densitometric evaluation, done with the Scion 
Image Programme, version v4.02β for Windows. Thresholding to the optical density 
level of the background staining was performed. A constant sized reference frame has 
been positioned onto each photo to include all immunopositive neurons. The resulting 
data (positivity in arbitrary units) reflect the immunopositive area within the reference 
frame (Fig. 1). The number of data varied between 34 and 42 per brain. These data 
were used as counts in the statistical analysis.
Statistical analysis
Statistical analysis was done by using the Stata13 software (StataCorp LP, USA). 
Unpaired t-tests have been performed at 95% confidence level. To check incidental 
consequences of slightly oblique section planes, density counts of left and right sides 
were compared. No significant differences have been found. Aggregate density 
counts at ZT0 and ZT12 (122 and 121) counts, respectively, as well as the means of 
density counts of the individual animals within and between the groups, have also 
been evaluated by t-test. 
RESULTS
Density count data, proportional with the level of immunopositivity have been 
obtained by densitometric evaluation of the immunolabelled brain sections, as illus-
trated in Figure 1.  Density count data appear on an arbitrary scale. Comparability of 
the data has been guaranteed by careful standardization of all experimental condi-
tions. Total hypothalamic MCH levels of individual mice have been assessed by the 
addition of density count data in all coronal hypothalamic sections depicting MCH 
neurons. Statistical comparison of aggregate density counts of all sections obtained 
from ZT0 and ZT12 mice has been performed. Box and whiskers plots (Fig. 2) indi-
cate that the distribution of density readings is highly skewed. Even if the data do not 
follow normal distribution, due to the large number of data (121 and 122, respec-
tively), the t-test (with equal variances) could be used for statistical comparison. 
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The means, CI (95%) and medians for ZT0 and ZT12 were 122.57 (98.70–146.4), 87 
and 182.04 (153.6–210.5) and 128, respectively.  The difference between the data at 
the two diurnal time points, ZT0 and ZT12 was significant (p = 0.0017, CI (95%): 
22.54–96.40). Non-parametric tests (Kolmogorov–Smirnov and Shapiro–Wilk) also 
showed significant difference between ZT0 and ZT12 (data not shown).
Although the observed difference is highly significant, extension of the experi-
ments to a higher number of animals is planned. 
DISCUSSION
MCH neurons are known to be involved in circuits influencing feeding behaviour and 
sleep-wake rhythm. Therefore, it seemed to be highly conceivable that their peptide 
content followed circadian pattern. 
Former studies addressed this point by diverse approaches. Harthoorn et al. [9] 
selected 25 MCH neurons in the rat hypothalamus and found that their MCH content 
did not depend on the diurnal time point. Likewise, the expression profile of the Pmch 
gene did not exhibit particularly strong circadian expression profile in mice [20], 
similarly to several other genes regulating food intake. Dias Abdo Agamme et al. [6] 
also observed absence of day/night differences in Pmch expression in the rat hypo-
thalamus under undisturbed conditions. 
Fig. 2. Box and whisker plots of density count data demonstrate significantly lower MCH level in the 
hypothalamus at the end of the active period (ZT0) than at the end of the sleeping period (ZT12)
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It is worth noting, however, that the time of the day has been found to influence 
the response of the MCHergic system to abnormal conditions, e.g. fasting [19] or 
sleep disruption [6].
The aim of the work presented here was to compare the amount of MCH peptide 
present in the whole MCH neuron population of mice at the end of the active (dark) 
and the sleeping (light) periods. MCH peptide levels were assessed by densitometric 
evaluation of immunohistochemically labelled sections. MCH content of the whole 
hypothalamic MCH neuron population was calculated by adding up the MCH content 
of all coronal sections containing MCH neuron perikarya. Type A and type B MCH 
neuron subpopulations were not distinguished. The MCH level calculated this way 
has proven to be significantly lower at the end of the active period (ZT0) as compared 
to the end of the sleeping period (ZT12). This result implies that the replenishment 
and/or the depletion of the MCH pool depends on the time of the day. Depletion of 
the hypothalamic MCH pool is supposed to depend mostly on the activity dependent 
transport of the neuropeptide to its multiple target sites. For the time being, the rate 
and regulation of this transport process is unidentified. To address this issue, the pos-
sible diurnal variation of the MCH level in the various target areas should be studied 
as well. As far as the replenishment of the pool is concerned, earlier results indicated 
that the level of Pmch gene expression, as characterized by the MCH mRNA level, 
does not depend on the time of the day [6, 20]. It is to be considered, that beyond 
transcription, formation of mature MCH involves translation of the mRNA to pre-
proMCH and the posttranslational proteolytic cleavage of the emerging prohormone 
[15, 23] as well. The possible circadian rhythm of these processes was not addressed 
yet. 
As a conclusion, the observed diurnal variation of the MCH peptide level in the 
hypothalamus is verisimilarly of physiological importance. Further investigations are 
needed to ascertain the underlying mechanisms. 
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